Nicolas Wolikow
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Nicolas Wolikow
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode of Visionaries of Health, Inga Bergen talks to Nicolas Wolikow, Co-Founder and CEO of Cure51 – a company on a mission to decode survival. Instead of focusing only on disease progression, Cure51 asks: Why do some people survive aggressive cancers – and what can we learn from them?
Nicolas shares how Cure51 collaborates with over 100 hospitals worldwide to identify so-called “Exceptional Survivors,” analyze their data, and use AI to find new therapeutic targets for cancers with very low survival rates. A powerful conversation about the future of oncology, the role of data in medicine – and how science and hope go hand in hand.
📌 This episode is in English.
Learn more about our podcast, all episodes, and your hosts – Inga Bergen & Larissa Middendorf – at:
🌐 www.visionaries-health.com
🎧 You’ll also find more inspiring conversations in our German podcast “Visionäre der Gesundheit”, available on all major podcast platforms.
📬 Want to suggest a topic or send us feedback?
Reach out anytime at: info@visionaere-gesundheit.de